Profile
Bo Ren Xue is the founder of ACT Genomics Co. Ltd. Mr. Xue is currently President, Chief Operating Officer & Director at AnBogen Therapeutics, Inc. since 2022.
Mr. Xue is also Vice President-Corporate Operations at TaiGen Biotechnology Co., Ltd. since 2001.
Formerly, Mr. Xue was President at AnBogen Therapeutics, Inc. Mr. Xue earned an MBA from Fairleigh Dickinson University in 1997 and completed undergraduate studies at Soochow University.
Bo Ren Xue active positions
| Companies | Position | Start |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | President | 01/05/2022 |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Chief Operating Officer | 02/10/2012 |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Founder | - |
Former positions of Bo Ren Xue
| Companies | Position | End |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | President | - |
Training of Bo Ren Xue
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Health Technology |
Soochow University
Soochow University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Health Services |
AnBogen Therapeutics, Inc.
AnBogen Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and sale of cancer precise medical drugs | Health Technology |
- Stock Market
- Insiders
- Bo Ren Xue
















